화학공학소재연구정보센터
검색결과 : 6건
No. Article
1 Cancer drug tackles overgrowth syndrome
Semple RK, Vanhaesebroeck B
Nature, 558(7711), 522, 2018
2 Inactivation of PI(3)K p110 delta breaks regulatory T-cell-mediated immune tolerance to cancer (vol 510, pg 407, 2014)
Ali K, Soond DR, Pineiro R, Hagemann T, Pearce W, Lim EL, Bouabe H, Scudamore CL, Hancox T, Maecker H, Friedman L, Turner M, Okkenhaug K, Vanhaesebroeck B
Nature, 535(7613), -, 2016
3 Inactivation of PI(3)K p110 delta breaks regulatory T-cell-mediated immune tolerance to cancer
Ali K, Soond DR, Pineiro R, Hagemann T, Pearce W, Lim EL, Bouabe H, Scudamore CL, Hancox T, Maecker H, Friedman L, Turner M, Okkenhaug K, Vanhaesebroeck B
Nature, 510(7505), 407, 2014
4 Human platelets contain p110 delta phosphoinositide 3-kinase
Zhang J, Vanhaesebroeck B, Rittenhouse SE
Biochemical and Biophysical Research Communications, 296(1), 178, 2002
5 Cloning and Characterization of a G-Protein-Activated Human Phosphoinositide-3 Kinase
Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R, Nurnberg B, Gierschik P, Seedorf K, Hsuan JJ, Waterfield MD, Wetzker R
Science, 269(5224), 690, 1995
6 Phosphatidylinositol-3-Oh Kinase as a Direct Target of Ras
Rodriguezviciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J
Nature, 370(6490), 527, 1994